scholarly journals Drug pipeline 2Q21—accelerated approvals to the fore

2021 ◽  
Vol 39 (8) ◽  
pp. 904-905
Author(s):  
Laura DeFrancesco
Keyword(s):  
Drug Pipeline

Obesity Drug Pipeline Grumbling With Hunger

2011 ◽  
Vol 41 (16) ◽  
pp. 41
Author(s):  
BRUCE JANCIN
Keyword(s):  
Drug Pipeline

Drug pipeline: 2Q19

2019 ◽  
Vol 37 (8) ◽  
pp. 840-841
Author(s):  
Laura DeFrancesco
Keyword(s):  
Drug Pipeline

Drug pipeline 4Q13

2014 ◽  
Vol 32 (2) ◽  
pp. 125-125
Author(s):  
Laura DeFrancesco
Keyword(s):  
Drug Pipeline

Drug pipeline: Q412

2013 ◽  
Vol 31 (3) ◽  
pp. 190-190 ◽  
Author(s):  
Laura DeFrancesco
Keyword(s):  
Drug Pipeline

Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline

2015 ◽  
Vol 1 (10) ◽  
pp. 877-894 ◽  
Author(s):  
Megan C. Cox ◽  
Laura M. Reese ◽  
Lissett R. Bickford ◽  
Scott S. Verbridge
Keyword(s):  
Cancer Drug ◽  
Tumor Models ◽  
Drug Pipeline

In vivo MR in the drug pipeline

2018 ◽  
Vol 292 ◽  
pp. 117-128 ◽  
Author(s):  
Jeffrey L. Evelhoch
Keyword(s):  
Drug Pipeline

SWINGS AND ROUNDABOUTS IN CNS DRUG BIOMARKERS

2017 ◽  
pp. 1-2
Author(s):  
M.B. Isaac ◽  
S. Vamvakas
Keyword(s):  
Central Nervous System ◽  
Drug Development ◽  
Unmet Needs ◽  
Healthcare Systems ◽  
Clinical Failure ◽  
Cns Disorders ◽  
Alzheimer Dementia ◽  
Development Costs ◽  
Cns Drugs ◽  
Drug Pipeline

Despite substantial advances in the understanding of central nervous system (CNS) disorders, healthcare systems worldwide face an unprecedented challenge in dealing with the unmet needs in this area (1). Meanwhile, the CNS drug pipeline looks worryingly dry. There are several reasons for this, including the obvious complexity of the CNS, a lack of interdisciplinary collaborations, increased drug development costs and the higher risk of clinical failure of CNS drugs, compared with those in other areas of drug development. The year 2016 was also disappointing in terms of failed trials of Alzheimer’ Dementia (AD) drugs.

scholarly journals Flooded by the torrent: the COVID-19 drug pipeline

The Lancet ◽  
2020 ◽  
Vol 395 (10232) ◽  
pp. 1245-1246 ◽  
Author(s):  
Asher Mullard
Keyword(s):  
Drug Pipeline
Sign in / Sign up

Export Citation Format

Share Document